Advanced search
Publication Cover
HIV Clinical Trials Volume 19, 2018 - Issue 6
Submit an article Journal homepage
626
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Participant characteristics and clinical trial decision-making factors in AIDS malignancy consortium treatment trials for HIV-infected persons with cancer (AMC #S006)

Jack E. BurkhalterDepartment of Psychiatry & Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA; View further author information
,
David M. AboulafiaDepartment of Hematology/Oncology, Virginia Mason Medical Center, Seattle, WA, USA (Retired); Correspondence[email protected]
View further author information
,
Maria Botello-HarbaumThe Emmes Corporation, Rockville, MD, USA; View further author information
&
Jeannette Y. LeeAIDS Malignancy Center Statistical Center, University of Arkansas for Medical Sciences, Little Rock, AR, USAView further author information
Pages 235-241 | Received 21 May 2018, Accepted 12 Oct 2018, Published online: 20 Mar 2019

References

  • Little RF. Cancer clinical trials in persons with HIV infection. Curr Opin HIV AIDS. 2017;12(1):84–88.
  • Suneja G, Lin CC, Simard EP, Han X, Engels EA, Jemal A. Disparities in cancer treatment among patients infected with the human immunodeficiency virus. Cancer. 2016;122(15):2399–2407.
  • Antiretroviral Therapy Cohort Collaboration. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV. 2017;4(8):e349–e356.
  • Shiels MS, Pfeiffer RM, Gail MH, et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst. 2011;103(9):753–762.
  • Deeken JF, Tjen ALA, Rudek MA, et al. The rising challenge of non-AIDS-defining cancers in HIV-infected patients. Clin Infect Dis. 2012;55(9):1228–1235.
  • Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370(9581):59–67.
  • Hernandez-Ramirez RU, Shiels MS, Dubrow R, Engels EA. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study. Lancet HIV. 2017;4(11):e495–e504.
  • Colon-Lopez V, Shiels MS, Machin M, et al. Anal cancer risk among people with HIV infection in the United States. J Clin Oncol. 2018;36(1):68–75.
  • Coghill AE, Shiels MS, Suneja G, Engels EA. Elevated cancer-specific mortality among HIV-infected patients in the United States. J Clin Oncol. 2015;33(21):2376–2383.
  • Coghill AE, Pfeiffer RM, Shiels MS, Engels EA. Excess mortality among HIV-infected individuals with cancer in the United States. Cancer Epidemiol Biomarker Prev. 2017;26(7):1027–1033.
  • Sigel K, Dubrow R, Silverberg M, Crothers K, Braithwaite S, Justice A. Cancer screening in patients infected with HIV. Curr HIV/AIDS Rep. 2011;8(3):142–152.
  • AIDS Malignancy Consortium. http://pub.emmes.com/study/amc/public/index.htm.
  • Frew PM, Hou SI, Davis M, et al. The likelihood of participation in clinical trials can be measured: the Clinical Research Involvement Scales. J Clin Epidemiol. 2010;63(10):1110–1117.
  • Ford JG, Howerton MW, Lai GY, et al. Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer. 2008;112(2):228–242.
  • Denicoff AM, McCaskill-Stevens W, Grubbs SS, et al. The national cancer institute-American Society of Clinical Oncology cancer trial accrual symposium: summary and recommendations. J Oncol Pract. 2013;9(6):267–276.
  • Mills E, Wilson K, Rachlis B, et al. Barriers to participation in HIV drug trials: a systematic review. Lancet Infect Dis. 2006;6(1):32–38.
  • Daugherty C, Ratain MJ, Grochowski E, et al. Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol. 1995;13(5):1062–1072.
  • Uldrick TS, Ison G, Rudek MA, et al. Modernizing clinical trial eligibility criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research HIV Working Group. J Clin Oncol. 2017;35(33):3774–3780.
  • Eggly S, Albrecht TL, Harper FW, Foster T, Franks MM, Ruckdeschel JC. Oncologists' recommendations of clinical trial participation to patients. Patient Educ Couns. 2008;70(1):143–148.
  • Ellis PM, Dowsett SM, Butow PN, Tattersall MH. Attitudes to randomized clinical trials amongst out-patients attending a medical oncology clinic. Health Expect. 1999;2(1):33–43.
  • Truong TH, Weeks JC, Cook EF, Joffe S. Altruism among participants in cancer clinical trials. Clin Trials. 2011;8(5):616–623.
  • Dhalla S, Poole G. Motivators to participation in medical trials: the application of social and personal categorization. Psychol Health Med. 2013;18(6):664–675.
  • George S, Duran N, Norris K. A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific Islanders. Am J Public Health. 2014;104(2):e16–e31.
  • Vines AI, Melvin CL, Hunter JC, Carlisle VA. Project ACCRUE: Exploring eptions to increase awareness of AIDS Malignancy Consortium clinical trials in North Carolina. N C Med J. 2017;78(2):84–91.
  • Centers for Disease Control and Prevention. Behavioral and Clinical Characteristics of Persons Receiving Medical Care for HIV Infection—Medical Monitoring Project, United States, 2014 Cycle (June 2014–May 2015). http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Published December 2016.
  • Janakiram M, Jasra S, Aboulafia D. Effect of hepatitis B and C infection on recruitment for cancer clinical trials. J Clin Oncol. 2018;36(10):1047–1048.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.